The Spot Sign for Predicting and Treating ICH Growth Study

NCT00810888 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

92

Enrollment

OTHER

Sponsor class

Conditions

Intracerebral Hemorrhage

Interventions

DRUG: recombinant activated factor VII
DRUG: placebo

Sponsor

University of Cincinnati

Collaborators

[object Object]